Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
5.18M
-
Shares change
-
-253K
-
Total reported value, excl. options
-
$37.1M
-
Value change
-
-$1.8M
-
Number of buys
-
17
-
Number of sells
-
-13
-
Price
-
$7.15
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q2 2015
43 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q2 2015.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.18M shares
of 15M outstanding shares and own 34.63% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (1.51M shares), DIMENSIONAL FUND ADVISORS LP (854K shares), MILLENNIUM MANAGEMENT LLC (616K shares), BlackRock Institutional Trust Company, N.A. (464K shares), VANGUARD GROUP INC (284K shares), RENAISSANCE TECHNOLOGIES LLC (197K shares), NEW YORK STATE COMMON RETIREMENT FUND (176K shares), ACADIAN ASSET MANAGEMENT LLC (174K shares), Invesco Ltd. (84.7K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (84K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.